Evidence map›Paper›PMID 22522092›Full record

ArticleGastroenterology2012

Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice.

Gerhard Wingender, Dariusz Stepniak, Philippe Krebs, Lin Lin, Sara McBride, Bo Wei, Jonathan Braun, Sarkis K Mazmanian, Mitchell Kronenberg

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 215 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Frontiers in immunology · 2023
    Review
  19. Review
  20. Review

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Gerhard WingenderLa Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
Dariusz Stepniak
Philippe Krebs
Lin Lin
Sara McBride
Bo Wei
Jonathan Braun
Sarkis K Mazmanian
Mitchell Kronenberg
La Jolla Institute for Immunology · USUniversity of California, Los Angeles · USCalifornia Institute of Technology · USUniversity of Bern · CH

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
Protection from Mucosal Pathology by Gut Microflora during Experimental ColitisR01DK078938 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2009 to 2020
$5.1M
Development and Function of NKT CellsR37AI071922 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2006 to 2015
$4.9M
Recognition of bacterial antigens by NKT cellsR01AI045053 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2000 to 2010
$3.3M
Indirect recognition of microbes by NKT cellsR01AI069296 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2007 to 2011
$2.1M
Protection from Mucosal Pathology by Gut Microbiota During Experimentas ColitisR56DK078938 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2016 to 2016
$618k
NCATS NIH HHS UL1 TR000124NCRR NIH HHS UL1 RR033176NIAID NIH HHS R01 AI045053NIAID NIH HHS R01 AI069296NIAID NIH HHS R01 AI45053NIAID NIH HHS R37 AI071922NIAID NIH HHS R37 AI71922NIDDK NIH HHS DK078938NIDDK NIH HHS P01 DK046763NIDDK NIH HHS R01 DK078938NIDDK NIH HHS R56 DK078938
6 · The paper itself

Abstract

BACKGROUND &

aimsInvariant natural killer T (iNKT) cells undergo canonical, Vα14-Jα18 rearrangement of the T-cell receptor (TCR) in mice; this form of the TCR recognizes glycolipids presented by CD1d. iNKT cells mediate many different immune reactions. Their constitutive activated and memory phenotype and rapid initiation of effector functions after stimulation indicate previous antigen-specific stimulation. However, little is known about this process. We investigated whether symbiotic microbes can determine the activated phenotype and function of iNKT cells.

methodsWe analyzed the numbers, phenotypes, and functions of iNKT cells in germ-free mice, germ-free mice reconstituted with specified bacteria, and mice housed in specific pathogen-free environments.

resultsSpecific pathogen-free mice, obtained from different vendors, have different intestinal microbiota. iNKT cells isolated from these mice differed in TCR Vβ7 frequency and cytokine response to antigen, which depended on the environment. iNKT cells isolated from germ-free mice had a less mature phenotype and were hyporesponsive to activation with the antigen α-galactosylceramide. Intragastric exposure of germ-free mice to Sphingomonas bacteria, which carry iNKT cell antigens, fully established phenotypic maturity of iNKT cells. In contrast, reconstitution with Escherichia coli, which lack specific antigens for iNKT cells, did not affect the phenotype of iNKT cells. The effects of intestinal microbes on iNKT cell responsiveness did not require Toll-like receptor signals, which can activate iNKT cells independently of TCR stimulation.

conclusionsIntestinal microbes can affect iNKT cell phenotypes and functions in mice.

Indexed as

Escherichia coliLymphocyte ActivationSphingomonasAnimalsBiomarkersCytokinesFlow CytometryGalactosylceramidesGene Rearrangement, beta-Chain T-Cell Antigen ReceptorGerm-Free LifeIntestinesMiceMice, Inbred C57BLNatural Killer T-CellsPhenotypeReceptors, Antigen, T-Cellalpha-galactosylceramideBiomarkersCytokinesGalactosylceramidesReceptors, Antigen, T-Cell

Identifiers

PMID22522092
PMCPMC3404247
OpenAlexW2118697254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.